Stock Events

Hologic 

$76.15
68
+$0.27+0.36% Friday 21:00

Statistics

Day High
76.48
Day Low
75.64
52W High
87.88
52W Low
64.02
Volume
1,417,898
Avg. Volume
2,082,232
Mkt Cap
17.87B
P/E Ratio
36.44
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29AprExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Next
0.63
0.78
0.92
1.07
Expected EPS
0.98
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HOLX. It's not an investment recommendation.

Analyst Ratings

82.2$Average Price Target
The highest estimate is $90.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
40%
Hold
60%
Sell
0%

About

Health Technology
Medical Specialties
Manufacturing
Irradiation Apparatus Manufacturing
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
Show more...
CEO
Stephen MacMillan
Employees
6705
Country
US
ISIN
US4364401012
WKN
000879100

Listings